Cathy N Lam
Examiner (ID: 12915)
Most Active Art Unit | 2811 |
Art Unit(s) | 4122, 2811 |
Total Applications | 430 |
Issued Applications | 305 |
Pending Applications | 0 |
Abandoned Applications | 125 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5297220
[patent_doc_number] => 20090012146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'SOLUBILITY-ENHANCED PHARMACEUTICAL COMPOSITIONS COMPRISING ZAFIRLUKAST'
[patent_app_type] => utility
[patent_app_number] => 12/166493
[patent_app_country] => US
[patent_app_date] => 2008-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9337
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012146.pdf
[firstpage_image] =>[orig_patent_app_number] => 12166493
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/166493 | SOLUBILITY-ENHANCED PHARMACEUTICAL COMPOSITIONS COMPRISING ZAFIRLUKAST | Jul 1, 2008 | Abandoned |
Array
(
[id] => 6231799
[patent_doc_number] => 20100184779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'METHOD FOR OPTIMIZING THE TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH ABL TYROSINE KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/665615
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4562
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184779.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665615
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665615 | METHOD FOR OPTIMIZING THE TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH ABL TYROSINE KINASE INHIBITORS | Jun 19, 2008 | Abandoned |
Array
(
[id] => 6426988
[patent_doc_number] => 20100168243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'Renin Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/665222
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31241
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168243.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665222
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665222 | Renin Inhibitors | Jun 19, 2008 | Abandoned |
Array
(
[id] => 4710671
[patent_doc_number] => 20080299197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Triple Combination Release Multi-Layered Tablet'
[patent_app_type] => utility
[patent_app_number] => 12/141677
[patent_app_country] => US
[patent_app_date] => 2008-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 25128
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12141677
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/141677 | Triple combination release multi-layered tablet | Jun 17, 2008 | Issued |
Array
(
[id] => 6276293
[patent_doc_number] => 20100256206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'CRYSTALLINE FORM B OF OLMESARTAN MEDOXOMIL'
[patent_app_type] => utility
[patent_app_number] => 12/602948
[patent_app_country] => US
[patent_app_date] => 2008-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6213
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256206.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602948 | CRYSTALLINE FORM B OF OLMESARTAN MEDOXOMIL | Jun 4, 2008 | Abandoned |
Array
(
[id] => 8028689
[patent_doc_number] => 08143424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Thyroid like compounds'
[patent_app_type] => utility
[patent_app_number] => 12/224168
[patent_app_country] => US
[patent_app_date] => 2008-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 30280
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/143/08143424.pdf
[firstpage_image] =>[orig_patent_app_number] => 12224168
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/224168 | Thyroid like compounds | Jun 1, 2008 | Issued |
Array
(
[id] => 8352078
[patent_doc_number] => 08247407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-21
[patent_title] => 'Pharmaceutical composition with anti-diabetic action'
[patent_app_type] => utility
[patent_app_number] => 12/673243
[patent_app_country] => US
[patent_app_date] => 2008-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 9
[patent_no_of_words] => 5301
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673243
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/673243 | Pharmaceutical composition with anti-diabetic action | May 21, 2008 | Issued |
Array
(
[id] => 6426353
[patent_doc_number] => 20100168191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'PHARMACEUTICAL FORMULATION COMPRISING PRAMIPEXOLE'
[patent_app_type] => utility
[patent_app_number] => 12/601403
[patent_app_country] => US
[patent_app_date] => 2008-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2047
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20100168191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12601403
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601403 | PHARMACEUTICAL FORMULATION COMPRISING PRAMIPEXOLE | May 9, 2008 | Abandoned |
Array
(
[id] => 6296510
[patent_doc_number] => 20100240659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11SS-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/599133
[patent_app_country] => US
[patent_app_date] => 2008-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 187242
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240659.pdf
[firstpage_image] =>[orig_patent_app_number] => 12599133
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/599133 | Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity | May 6, 2008 | Issued |
Array
(
[id] => 8244955
[patent_doc_number] => 08202885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Bridged six-membered ring compounds'
[patent_app_type] => utility
[patent_app_number] => 12/597817
[patent_app_country] => US
[patent_app_date] => 2008-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59405
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202885.pdf
[firstpage_image] =>[orig_patent_app_number] => 12597817
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597817 | Bridged six-membered ring compounds | Apr 24, 2008 | Issued |
Array
(
[id] => 6320303
[patent_doc_number] => 20100113330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'TETRAHYDROPYRIDO[4,3-D]PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/594044
[patent_app_country] => US
[patent_app_date] => 2008-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22791
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113330.pdf
[firstpage_image] =>[orig_patent_app_number] => 12594044
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594044 | TETRAHYDROPYRIDO[4,3-D]PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF | Apr 16, 2008 | Abandoned |
Array
(
[id] => 9552279
[patent_doc_number] => 08759327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism'
[patent_app_type] => utility
[patent_app_number] => 12/104409
[patent_app_country] => US
[patent_app_date] => 2008-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 43
[patent_no_of_words] => 31870
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12104409
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/104409 | Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism | Apr 15, 2008 | Issued |
Array
(
[id] => 8189348
[patent_doc_number] => 08183236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics'
[patent_app_type] => utility
[patent_app_number] => 12/102619
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13381
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183236.pdf
[firstpage_image] =>[orig_patent_app_number] => 12102619
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/102619 | Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics | Apr 13, 2008 | Issued |
Array
(
[id] => 9648055
[patent_doc_number] => 08802065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Aqueous preservative solution with high amino acid content'
[patent_app_type] => utility
[patent_app_number] => 12/101467
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11022
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12101467
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101467 | Aqueous preservative solution with high amino acid content | Apr 10, 2008 | Issued |
Array
(
[id] => 8875865
[patent_doc_number] => 08470832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Co-crystals'
[patent_app_type] => utility
[patent_app_number] => 12/593339
[patent_app_country] => US
[patent_app_date] => 2008-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 8393
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593339
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/593339 | Co-crystals | Mar 26, 2008 | Issued |
Array
(
[id] => 4718550
[patent_doc_number] => 20080241072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION'
[patent_app_type] => utility
[patent_app_number] => 12/054990
[patent_app_country] => US
[patent_app_date] => 2008-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5245
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241072.pdf
[firstpage_image] =>[orig_patent_app_number] => 12054990
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/054990 | INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION | Mar 24, 2008 | Abandoned |
Array
(
[id] => 5937479
[patent_doc_number] => 20110212933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'Antiseptic Compositions for the Treatment of Infections'
[patent_app_type] => utility
[patent_app_number] => 12/933358
[patent_app_country] => US
[patent_app_date] => 2008-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51456
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212933.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933358
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933358 | Antiseptic Compositions for the Treatment of Infections | Mar 19, 2008 | Abandoned |
Array
(
[id] => 4886453
[patent_doc_number] => 20080260785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'PAROXETINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/051589
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6803
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260785.pdf
[firstpage_image] =>[orig_patent_app_number] => 12051589
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/051589 | PAROXETINE COMPOSITIONS | Mar 18, 2008 | Abandoned |
Array
(
[id] => 6432494
[patent_doc_number] => 20100152213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'COMPOUND THAT IS A DUAL INHIBITOR OF ENZYMES PDE7 AND/OR PDE4, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/532104
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12198
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152213.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532104
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532104 | COMPOUND THAT IS A DUAL INHIBITOR OF ENZYMES PDE7 AND/OR PDE4, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Mar 13, 2008 | Abandoned |
Array
(
[id] => 7682243
[patent_doc_number] => 20100022565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/529359
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29866
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022565.pdf
[firstpage_image] =>[orig_patent_app_number] => 12529359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/529359 | PHARMACEUTICAL COMPOSITIONS | Feb 28, 2008 | Abandoned |